Procter & Gamble stock reports 1.5 percent growth

Procter & Gamble stock was trading at USD 147.84 on the NYSE on September 24, 2026, up USD 0.45 or 0.31 percent from the previous close. The latest quarterly figures showed EPS of USD 1.43 against a consensus estimate of USD 1.41, according to MarketBeat.

Quarterly EPS beats estimate

The USD 0.02 EPS advantage was the clearest positive in the latest report. It also compares with EPS of USD 1.48 in the same period last year, putting the current result USD 0.05 lower on that basis, as MarketBeat reported.

Management guidance cited by MarketBeat puts fiscal 2027 EPS at USD 6.890 to USD 7.110. The range gives investors a concrete benchmark for judging whether earnings can expand after the latest quarter.

Revenue grows 1.5 percent

Quarterly revenue reached USD 21.20 billion, up 1.5 percent from the same period a year earlier. The figure nevertheless came in below the USD 21.38 billion analyst expectation, a USD 0.18 billion shortfall that limits the positive message from the EPS beat, according to MarketBeat.

The combination of 1.5 percent revenue growth and an EPS beat points to a business that is still expanding, but with sales momentum below expectations. That makes the next update on organic growth and margins more important than the headline earnings beat alone.

Stock trades below target

MarketBeat lists a Moderate Buy consensus from 23 research firms and an average 12-month price target of USD 161.55. Against the USD 147.84 intraday price, that target is USD 13.71 higher, while the current quote remains inside the 52-week range of USD 137.62 to USD 167.25.

Procter & Gamble shares therefore sit USD 19.41 below the 52-week high and USD 10.22 above the low. The stock's market capitalization was USD 351,446,569,246 on September 24, 2026, giving the quarterly revenue and EPS figures a large-cap valuation context.